Libni J Eapen
Overview
Explore the profile of Libni J Eapen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
233
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study
Ballas L, Sargos P, Orre M, Bian S, Daneshmand S, Eapen L
Clin Genitourin Cancer
. 2017 Jun;
15(6):711-716.
PMID: 28558986
Background: The present retrospective study analyzed the tolerance of orthotopic ileal neobladders to radiotherapy by reviewing the acute and late toxicity in patients who underwent postoperative radiotherapy after radical cystectomy/cystoprostatectomy....
2.
Baumann B, Sargos P, Eapen L, Efstathiou J, Choudhury A, Bahl A, et al.
Bladder Cancer
. 2017 Feb;
3(1):19-30.
PMID: 28149931
Local-regional recurrence for patients with ≥pT3 disease after radical cystectomy is a significant problem. Chemotherapy has not been shown to reduce the risk of local-regional recurrences in randomized prospective trials,...
3.
Christodouleas J, Eapen L, Baumann B
Int J Radiat Oncol Biol Phys
. 2016 Nov;
96(5):1128-1129.
PMID: 27869090
No abstract available.
4.
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
Sargos P, Baumann B, Eapen L, Bahl A, Murthy V, Roubaud G, et al.
Transl Androl Urol
. 2016 Oct;
5(5):702-710.
PMID: 27785427
Radical cystectomy with extended pelvic lymph-node dissection, associated with neo-adjuvant chemotherapy, remains the standard of care for advanced, non-metastatic muscle-invasive bladder cancer (MIBC). Loco-regional control is a key factor in...
5.
Baumann B, Bosch W, Bahl A, Birtle A, Breau R, Challapalli A, et al.
Int J Radiat Oncol Biol Phys
. 2016 Aug;
96(1):78-86.
PMID: 27511849
Purpose: To develop multi-institutional consensus clinical target volumes (CTVs) and organs at risk (OARs) for male and female bladder cancer patients undergoing adjuvant radiation therapy (RT) in clinical trials. Methods...
6.
7.
Eapen L, Jones E, Kassouf W, Lambert C, Morgan S, Moussa M, et al.
Can Urol Assoc J
. 2016 May;
10(3-4):90-4.
PMID: 27217852
Introduction: We aimed to enumerate the rate of pelvic recurrence following radical cystectomy at university-affiliated hospitals in Canada. Methods: Canadian, university-affiliated hospitals were invited to participate. They were asked to...
8.
Milowsky M, Rumble R, Booth C, Gilligan T, Eapen L, Hauke R, et al.
J Clin Oncol
. 2016 Mar;
34(16):1945-52.
PMID: 27001593
Purpose: To endorse the European Association of Urology guideline on muscle-invasive (MIBC) and metastatic bladder cancer. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures...
9.
Groome P, OSullivan B, Mackillop W, Jackson L, Schulze K, Irish J, et al.
Int J Radiat Oncol Biol Phys
. 2006 Jan;
64(4):1002-12.
PMID: 16414205
Purpose: This population-based study describes the treatment of early glottic cancer in Ontario, Canada and assesses whether treatment variations were associated with treatment effectiveness. Methods And Materials: We studied 491...
10.
Groome P, OSullivan B, Irish J, Rothwell D, Schulze K, Warde P, et al.
J Clin Oncol
. 2003 Feb;
21(3):496-505.
PMID: 12560441
Purpose: We compared the management and outcome of supraglottic cancer in Ontario, Canada, with that in the Surveillance, Epidemiology, and End Results (SEER) Program areas in the United States. Methods:...